2nd Annual Antibody Summit: Discovery, Engineering and Therapeutics

This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development.

The Summit will shed light on current challenges, best practices and the inside view of the future of Antibodies.

We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in the Antibodies.

Key Practical Learning Points of the Summit:

  • 360° view of Antibody from key industry players to leverage your business and scientific practice adoption
  • Emerging discoveries, cutting-edge knowledge, tools, methods, and technologies to bring clinically safe and efficient Antibodies
  • Novel approaches and Antibody formats to accelerate Antibody therapeutics

Who Should Attend:

Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, Managers, Clinical Development Experts and Scientists specialising in

  • Antibody & Biologics Discovery /Development
  • Manufacturing/CMC
  • Protein Engineering
  • Molecular Biology
  • Medicinal Chemistry
  • Antibody-drug conjugates (ADCs)
  • Bioconjugates
  • Immunoconjugates
  • Monoclonal antibodies (mAbs)
  • Maytansine
  • Tubulysins
  • Duocarmycin
  • PBD-dimers
  • α-amanitin
  • Topoisomerase inhibitors
  • Marine-based cytotoxins
  • Small-molecule drug conjugates
  • Peptide-drug conjugates
  • Nanoparticles/Nanobodies
  • Diabodies/Minibodies
  • PKPD
  • ADME
  • Toxicology
  • Analytical & Formulation
  • Bioanalysis
  • Cancer
  • Oncology
  • Hematology
  • Antibody-based therapeutics
  • Biotherapeutics
  • Immunotherapeutics
  • Chemotherapeutics
Media partners